Ismail Sarbay, MD ☕

2.1K posts

Ismail Sarbay, MD ☕ banner
Ismail Sarbay, MD ☕

Ismail Sarbay, MD ☕

@ismailsarbay

Thoracic Surgeon | researcher | illustrator | 🔎 ESTS Robotic Working Group | 🔬IALSC Committee Member Lung Cancer Staging | 🖋 TÜSAD GEAK Group | @opereysin

Istanbul, Turkey Katılım Mart 2010
191 Takip Edilen387 Takipçiler
Ismail Sarbay, MD ☕ retweetledi
CTSNet
CTSNet@ctsnetorg·
Parenchyma-Sparing Robotic Sleeve Resection of the Left Lower Lobe Bronchus This excellent video demonstrates a patient with recurrent pneumonia due to an obstructing left lower lobe bronchial neuroendocrine tumor without metastasis. #cancer  🔗ow.ly/JzsB50Y7Q9Z
English
0
2
3
527
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
As Dr Motoko Tachihara underlined clearly the aim of multimodality approach is to achieve cure or disease control via whether straight forward surgery or salvage surgery whether neoadjuvant or definitive chemo-IO. @AATSHQ
Ismail Sarbay, MD ☕ tweet media
English
0
0
2
285
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Dr Hiroshi Date from Duke University discussed the techniques of bronchial stump management in a resection case after RT. @AATSHQ
Ismail Sarbay, MD ☕ tweet media
English
1
1
10
1K
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Dr @TokerAlper discussed the effect of TKI treatment prior to lung resection in the era of personalized multidisciplinary cancer treatment options. @AATSHQ
Ismail Sarbay, MD ☕ tweet media
English
0
1
9
842
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
On the second day of ITSOS Dr Watanabe is giving a great presentation about salvage surgery after radiotherapy @AATSHQ
Ismail Sarbay, MD ☕ tweet media
English
0
1
5
719
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Another intriguing presentation showing promising process of cancer vaccination studies. @AATSHQ
Ismail Sarbay, MD ☕ tweet mediaIsmail Sarbay, MD ☕ tweet media
English
0
0
0
68
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Last session of the first day is about mediastinal tumors, underlining the key points, multimodality strategies. @AATSHQ
Ismail Sarbay, MD ☕ tweet media
English
1
2
6
654
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
It was great to share expertise here and wide. @AATSHQ One of our robotic bronchial sleeve resection case presents such an example. A big chance to participate in these robotic cases as well as these high-level global meetings with @TokerAlper
Ismail Sarbay, MD ☕ tweet mediaIsmail Sarbay, MD ☕ tweet media
English
0
1
5
515
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Discussing in Boston MA, the pros and cons of new neoadjuvant treatment options. NEOADAURA trial promises less upstaging and more downstaging compared to chemo alone in patients with stage II and IIIB EGFRm NSCLC. @AATSHQ
Ismail Sarbay, MD ☕ tweet mediaIsmail Sarbay, MD ☕ tweet media
English
0
1
5
309
Ismail Sarbay, MD ☕ retweetledi
Alper Toker.
Alper Toker.@TokerAlper·
This is what I have perceived at 2014. Segment resections are the best for robotic surgery.
Alper Toker. tweet media
English
0
1
9
766
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
@ibrahimsarbay Modern tıbbın dayanağı olarak kabul edilen literatür için büyük tehlike. Yakın tarihte en büyük dergilerde bile retrakte edilen onlarca makale oldu. Tıbbi literatür balon gibi şişiriliyor mu acaba? Sonuçta bunlar daha Scopusta indekslenen yayınlar.
Türkçe
0
1
1
489
İbrahim Sarbay
İbrahim Sarbay@ibrahimsarbay·
Bu yıl HER İŞ GÜNÜ iki yayını basılan tam 22 yazar bulmuşlar. “Olur mu? Olursa nasıl olur?” diye soruyorlar.
Publishing with Integrity@fake_journals

. 22 people have published more than 200 papers in 2024 (so far, we still have another six months to go) We have been doing some research on another project and saw something that we found interesting. We'd be interested to know what you think. In 2024, 22 authors (according to @Scopus) have published over 200 papers. The table below shows the details (we decided not to show author names at this time). The author who has published the most papers has authored 261 papers (as at 15 Jun 2024) meaning that he/she has published 1.56 papers every day this year (and counting). If we exclude weekends (everybody has to rest, right?), then they have published 2.18 papers every day. Serious question: Is it possible for anybody to contribute in a meaningful way (at least to warrant being at author) when they are publishing a paper every day?

Türkçe
1
0
0
1K
Ismail Sarbay, MD ☕ retweetledi
İbrahim Sarbay
İbrahim Sarbay@ibrahimsarbay·
Türkiye Acil Tıp Vakfı 3. Uluslararası Acil Tıp Kongresi Next Generation İngilizce bilimsel sunum yarışmasında 3.’lük ödülü aldım. Just won the Bronze Award in Türkiye Emergency Medicine Foundation Next Generation scientific presentation contest.
İbrahim Sarbay tweet media
Türkçe
3
4
99
8.8K
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
Does segmentectomy really helps preverving lung functions better, what about local recurrence, survival rates, treatments… The future lies ahead of us. Multimodality approach should be key, that’s for sure!
English
0
0
1
150
Ismail Sarbay, MD ☕
Ismail Sarbay, MD ☕@ismailsarbay·
@TokerAlper , Dominique Gossot, Tim Batchelor and Wentao Fang discussed the rational behind lung cancer resection: Lobectomy vs segmentectomy, why and why not… at Turkish Thoracic Surgery Conference
Ismail Sarbay, MD ☕ tweet mediaIsmail Sarbay, MD ☕ tweet mediaIsmail Sarbay, MD ☕ tweet media
English
1
0
2
269

Keşfet

@AATSHQ @TokerAlper @ibrahimsarbay @emollick @gdb @OpenAI @AnthropicAI @elonmusk